Stockholders Equity
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Stockholders Equity

Note 9. Stockholders’ Equity

Authorized Shares

In connection with the completion of the Company’s IPO in July 2020, the Company amended its certificate of incorporation to authorize 250,000,000 shares of common stock, par value $0.0001 per share, and 10,000,000 shares of undesignated preferred stock, par value $0.0001 per share, that may be issued from time to time by the Company’s board of directors in one or more series. Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Company’s board of directors. Since the Company’s inception, there have been no dividends declared.

Public Offering and Related Transaction

In July 2020, the Company completed its IPO selling 14,000,000 shares of its common stock at a public offering price of $16.00 per share. Proceeds from the Company’s IPO, net of underwriting discounts and other offering costs, were $205.7 million. In connection with the IPO, all 42,953,085 shares of outstanding convertible preferred stock were automatically converted into 34,445,108 shares of the Company’s common stock. Additionally, the outstanding warrants to purchase an aggregate of 151,042 shares of convertible preferred stock became exercisable for 121,122 shares of common stock and were reclassified into permanent equity.

Convertible Preferred Stock

Prior to its conversion to common stock, the Company’s convertible preferred stock was classified as temporary equity on the Company’s balance sheets in accordance with authoritative guidance for the classification and measurement of potentially redeemable securities whose redemption is based upon certain change in control events outside of the Company’s control, including liquidation, sale or transfer of control of the Company. The Company had determined not to adjust the carrying values of the convertible preferred stock to the liquidation preferences of such shares because of the uncertainty of whether or when such events would occur.

In June 2020, the Company issued and sold 10,018,300 shares of Series D Preferred Stock, at a price of $10.93 per share, for aggregate gross proceeds of $109.5 million.

Convertible preferred stock immediately prior to the closing of the IPO consisted of the following (in thousands, except share amounts):

 

 

 

July 14, 2020

 

 

 

Preferred

Stock

Authorized

 

 

Preferred

Stock

Issued and

Outstanding

 

 

Carrying

Value

 

 

Liquidation

Preference

 

 

Common

Stock

Issuable

Upon

Conversion

 

Series A Preferred Stock

 

 

9,696,798

 

 

 

9,696,798

 

 

$

31,063

 

 

$

31,063

 

 

 

7,776,095

 

Series A-1 Preferred Stock

 

 

3,370,263

 

 

 

3,253,645

 

 

 

11,083

 

 

 

11,083

 

 

 

2,609,176

 

Series B Preferred Stock

 

 

5,283,992

 

 

 

5,249,568

 

 

 

30,314

 

 

 

30,314

 

 

 

4,209,754

 

Series C Preferred Stock

 

 

14,734,774

 

 

 

14,734,774

 

 

 

149,713

 

 

 

149,713

 

 

 

11,816,169

 

Series D Preferred Stock

 

 

13,723,696

 

 

 

10,018,300

 

 

 

104,140

 

 

 

104,140

 

 

 

8,033,914

 

Total

 

 

46,809,523

 

 

 

42,953,085

 

 

$

326,313

 

 

$

326,313

 

 

 

34,445,108

 

Common Stock

Each share of common stock is entitled to one vote. The holders of common stock are also entitled to receive dividends whenever funds are legally available and when declared by the Company’s board of directors. Since the Company’s inception, there have been no dividends declared.

Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consists of the following at December 31, 2021:

 

Stock options issued and outstanding

 

 

9,899,707

 

Authorized for future options and award grants

 

 

3,752,093

 

Authorized for future issuance under Employee

   Stock Purchase Plan

 

 

1,154,241

 

Total

 

 

14,806,041